Kromek is pioneering digital colour imaging for x-rays and has brought ground-breaking innovation to materials technology and advanced 3D imaging, that will literally change the way in which we see the world.


The Company specialises in making semiconductor materials within the Cadmium Telluride family. These materials have significant applications as detectors of x-rays and gamma rays, notably in medical imaging, security screening, industrial inspection and space exploration, allowing for very precise identification of materials.



Cadmium Zinc Telluride is also the material of choice as a substrate for the fabrication of infrared detectors in both civilian and military markets. In addition to its range of semiconductor materials, detector packages and non imaging detection systems Kromek also supplies x-ray imaging packages with multi view capabilities.

These x-ray display platforms provide real 3D x-ray imaging for the first time without specialist viewing equipment. When photogrammetric algorithms are applied to these images, three dimensional co-ordinate data is produced.

Kromek Group is listed on London's alternative Investment Market, AIM. Its ordinary shares carry the symbol KMK. Kromek Group plc is incorporated in England and Wales under the Companies Act 2006 (registration number 8661469). Its main countries of operation are the United Kingdom and the United States.

http://www.kromek.com/

Kromek, which designs, develops and produces x-ray imaging and radiation detection products using its core cadmium zinc telluride technology, could be set for a bonanza year in 2014 as a new European Union directive comes in at the end of January requiring all European airports to screen liquids, aerosols and gels presented at airport security with EC approved equipment.


http://www.proactiveinvestors.co.uk/columns/broker-spotlight/14941/broker-round-up-serco-conviviality-retail-kromek-rightmove-wood-group-14941.html

Up 8.27%

dc nice one, our TP is 100p, given New Year tips.

Cheers halifax.

Closed up 10.53%

Scan time halved for Kromek Identifier in new ECAC accreditation - 05 December 2013

Kromek has received certification from the European Civil Aviation regulatory authority, ECAC, for its new generation of liquid explosive detecting bottle scanners, the Kromek Identifier. The new Identifier models halve the previous scanning time, allowing the screening process to be completed in ten seconds, while still retaining the highest performance category in its class.



Commenting on the announcement, Kromek CEO Dr Arnab Basu said: "The accreditation for our new, shorter-cycle Identifier bottle scanner from ECAC proves the effectiveness of our technology and also reinforces our continued commitment to work in partnership with our customer base to improve our system and the quality of the user experience."

Dr Basu added: "What makes the Identifier unique is its ability to scan metal cans, Tetra Pak and foil pouches, in addition to all types of glass and plastic containers; this means the Kromek Identifier is the only ECAC Standard 3 approved system that can scan every container type with a simple one button operation."

Kromek also announced it has secured a number of orders from UK and European airports for the Identifier. As well as receiving orders from nine UK Airports, new orders have been secured to supply airports in Portugal, Cyprus, and Belgium, as well as existing installations to airports in Finland, Germany and Australia.

These orders coincide with the phase 1 implementation of a 3 phase International Civil Aviation Organization pathway, mandated in the EU, from January 2014 to January 2016. Phase 1 will initially mandate that all EU airports provide the security screening equipment needed to allow the passage of liquids through airports for connecting passengers. Ultimately, the objective of the EU and the rest of the world, is to relax travel restrictions on the passage of all liquids, aerosols and gels

sp moving higher 78.5p up 6.8%

UP over 8% :-))

Article in Shares - Lift off for Kromek.

Looser EU aviation regulations with regard to liquids on flights across Europe could drive demand for Kromek's x-ray bottle scanner technology. Analysts believe many airports will introduce the new kit through 2014 and stoke further share gains.

Had wondered if Kromek was capturing the US market, clearly they are -


Kromek completes second US acquisition


Tuesday, 23 April 2013


Multi-award winning Anglo-American platform technology firm Kromek, has today announced it has successfully completed its second US acquisition, that of Pennsylvania-based Endicott Interconnect Detection and Imaging Systems (EIDIS), a division of Endicott Interconnect Technologies Inc.

Formerly known as eV Products, EIDIS becomes a fully owned subsidiary of the Kromek Group and will be trading as eV Products Inc.

eV Products operates in a similar area to Kromek; it was the pioneer and has over two decades of experience in Cadmium Zinc Telluride (CZT) materials and detectors. eV Products remains a leading global manufacturer of CZT detectors that can be integrated into custom designed OEM components and subassemblies for medical imaging, nuclear, industrial and homeland security markets.

Employing over 40 staff in a 3,000m2 facility in Saxonburg, the company has a large suite of products, and brings with it a very wide range of skills, competencies, capabilities, capacity and IP.

Kromek CEO, Dr Arnab Basu said: “There are compelling reasons for making this acquisition, not least that it put puts Kromek Group in a strong position in the spectral radiation detection market by having the widest breadth of technology for detector materials production and manufacturing capability, and is further complemented by the ASIC and electronics capabilities of Kromek’s first acquisition, California-based NOVA, and the existing wide breadth of expertise of Kromek in the UK.”

“While Kromek’s business model has recently been focused on developing end-user products in nuclear and explosive detection market, EIDIS had remained focused on OEM components and subassemblies-based product range.”

“Combining Kromek and eV Products technology and IP will create an unparalleled company in the CZT industry, meeting the needs of customers in the medical, security, industrial and defense industries.”

Dr Basu added: “The Group now employs more than 100 people across its three facilities. This means that together with our worldwide distributors, Kromek is able to fully service a growing global customer base that reaches across the US, Europe, Asia, Pacific and Australia.

“This acquisition further demonstrates our continued commitment to expand business in the US; it’s part of a planned strategy of growth, expanding to meet growing customer demands in the US market. This acquisition also establishes Kromek’s ability to provide a domestic source and security of supply for US customers”

Tech sector tipped for even bigger things in 2014

By Jamie Nimmo

December 29 2013, 9:01am


Broker Panmure Gordon‘s top picks for 2014 also include many tech shares.

X-ray imaging company Kromek (LON:KMK) has fared well since offering shares to the public in October, rising 17p to 68p. And Panmure thinks it will continue to soar to 92p in 2014, with plenty to satisfy of news on the way.



http://www.proactiveinvestors.co.uk/companies/news/64480/tech-sector-tipped-for-even-bigger-things-in-2014-64480.html

Strong purchasing today.

Up just under 10% :-))

MBE for Kromek chief executive Dr Arnab Basu

http://www.darlingtonandstocktontimes.co.uk/news/10904948.MBE_for_Kromek_chief_executive_Dr_Arnab_Basu/?ref=var_0

Half Yearly Report

http://www.moneyam.com/action/news/showArticle?id=4735435

some potential no doubt but sales need to increase dramatically.

The global medical imaging market was valued at $24bn in 2013 and is expected to reach an annual value of $35bn by 2019. Within that market, the CT scanner and nuclear imaging segments, two of Kromek’s key areas, are expected to show the fastest rate of growth. The overall market for CT scanners is estimated to grow to a value of $5.1bn per annum by 2017, offering major opportunities and potential for growth for Kromek.

The European Civil Aviation Conference regulations which will bring about a partial lifting of the ban on the carriage of liquids on board aircraft by 31 January 2014, is driving demand for the Group’s bottle scanner product. It is thought that the addressable market for this product over the next three years is worth around £150m.

Kromek Group to showcase at the London Innovators and Investors Forum 2014

StockMarketWire.com

Kromek Group Plc (KMK) (LON:KMK) will be showcasing their company at the Shares Magazine/Cenkos Innovators and Investors Forum in London on 4th February 2014. This successful event is a one day conference and expo showcasing up to 40 leading technology companies in front of an invited audience of institutional and private investors. Companies present include: Allocate Software, Angle, Avanti Communications, Bango, Bond International Software, Brady, Cenkos Securities, CML Microsystems, Earthport, Eleco, Enables IT, Escher Group Holdings, Filtronic, Forbidden Technologies, Globo, Imperial Innovations, incadea, InternetQ, KBC Advanced Technologies, Kromek Group, Optimal Payments, Quindell, Regenersis, Rightster,Shares Magazine, StatPro and Transense Technologies. More companies to be announced. More details at: http://www.msmconferences.com/event/iif2014

At 3:33pm: (LON:KMK) Kromek Group PLC share price was +0.25p at 79.25p

Organised in partnership with Cenkos Securities and Shares magazine, the second Innovators & Investors Forum will take place on 4th February 2014 at the Business Design Centre, London N1.

The event aims to showcase up to 40 leading innovative and imaginative technology-led firms and to bring them together with the investment community. It combines both a company expo and an educational conference where delegates learn about a range of investment opportunities.

REGISTER NOW

Why attend?

This event gives you a platform to meet under one roof up to 40 technology-led companies, hear their messages during presentation seminars and engage in discussions with them on their stands.

The event is supported with an extensive conference program, including keynote speakers and company presentations.



Companies already confirmed for the 4th February 2014 include:

Allocate Software
Angle
Avanti Communications
Bango
Bond International Software
Brady
Cenkos Securities
CML Microsystems
Deltex Medical
Earthport
Eleco
Enables IT
Escher Group Holdings
Filtronic
Forbidden Technologies
Globo
Imperial Innovations
incadea
InternetQ
ITM Power
KBC Advanced Technologies
Kromek Group
Optimal Payments
Plastics Capital
Quindell
Regenersis
Rightster
StatPro
Transense Technologies


CONFERENCE AGENDA

The following session is dedicated to a mix of institutional investor and private investors.

11:40 Company presentation - Colin Miles, VP, Corporate Relations - InternetQ

11:55 Company presentation - Hank Uberoi, CEO - Earthport

12:10 Company presentation - Quindell

12:25 Company presentation - Dr Nigel Pitchford, Chief Investment Officer - Imperial Innovations

12:40 Lunch

The afternoon sessions are dedicated to private investors.

14:00 Keynote address - Richard Penny, Senior Fund Manager - Legal and General UK Alpha Trust

14:15 Russ Mould, Editor - Shares Magazine

14:30 Company presentation - Kromek Group

14:45 Company presentation - Joel Leonoff, President & CEO - Optimal Payments

15:00 Company presentation

15:15 Company presentation - Charlie Muirhead, CEO and Founder - Rightster

15:30 Company presentation - Caroline Brown, Executive Director & CFO - KBC Advanced Technologies

15:45 Coffee

16:15 Company presentation - Andrew Fabian, Group Finance Director - StatPro

16:30 Company presentation

16:45 Company presentation

17:00 Company presentation - Jonathan O’Connell, CFO - Escher Group Holdings

17:15 Company presentation - ITM Power

17:30 Close

The exhibition will be open from 10:45 to 17:30.

Coffee / lunch will be served within the exhibition.


This agenda is subject to change and alterations. More companies to be announced soon.

REGISTER NOW

The exhibition will be open from 10:45 to 17:30.

Coffee / lunch will be served within the exhibition.



This agenda is subject to change and alterations. More companies to be announced soon.



EXHIBITION

The exhibition will be open from 10:45 to 17:30.

Coffee / lunch will be served within the exhibition.



Dress code: business attire




VENUE
Business Design Centre
52 Upper Street
Islington
London N1 0QH

http://www.businessdesigncentre.co.uk/

Access map: http://www.businessdesigncentre.co.uk/VisitingUs

Closest tube station: Angel (3 min. walk) - Northern Line





SPONSOR


Cenkos Securities is an independent specialist securities firm focused on UK small and mid-cap companies.
We aim to be entrepreneurial, whilst seeking to establish long-term relationships with corporate and institutional clients.
Our directors and partners have on average more than 25 years' experience in the UK securities market. They have pioneered and led some of the most successful and innovative transactions in the UK securities market over the last decades.

REGISTER NOW

WATCH: Dr Arnab Basu, CEO of Kromek, provides an overview to BRR at the Innovators & Investors Forum

Click here to watch

New Orders Received in Medical Imaging

RNS


RNS Number : 0459B

Kromek Group PLC

27 February 2014






Embargoed until: 0700hrs, 27 February 2014



Kromek Group plc

("Kromek" or "the Company")

New Orders Received in Medical Imaging



Kromek, a supplier of patented radiation detection technologies to the medical, security and nuclear markets, announces that it has secured $845,000 of new orders to supply radiation detectors and integrated electronic components to a globally leading Original Equipment Manufacturer ('OEM') operating in the Dual Energy X-ray Bone Mineral Densitometry ('DEXA BMD') market. The total booking this fiscal year from this customer now exceeds $1.25 million.

DEXA BMD is the most accurate imaging technique to diagnose the strength and health of bones, allowing clinicians to accurately detect, monitor and treat Osteoporosis in patients. DEXA BMD is another medical diagnostic imaging modality where improved x-ray detection and imaging detail helps early diagnostics and intervention, which enables healthcare providers to operate more efficiently and manage costs against a backdrop of global healthcare budget pressures.

The new orders to supply detection components based on Kromek's Cadmium Zinc Telluride ('CZT') technology, are in addition to an existing contract the Company has in place with the OEM partner, in a global BMD market expected to surpass $895 million by 2017.

Commenting on the announcement, Arnab Basu, CEO of Kromek, said: "This latest order from this existing OEM partner builds on an important international relationship as we continue to see growth through expanding our geographic reach, particularly in Asia.

"Our work in BMD helps clinicians to detect and treat Osteoporosis earlier and is further validation of our technology and its capabilities in improving the efficacy of medical scanning technologies. This latest success adds to the encouraging progress we have seen in the wider medical imaging space, as evidenced by our announcement in November 2013 of a $990,000 contract to supply components to the nuclear medicine market, alongside the up to $5.3 million development contract we received in the x-ray CT scanning space. We have multiple blue-chip customers in the medical imaging sector and are seeing excellent traction in the adoption of our components. We look forward to announcing further progress in due course."

-ends-